Azilsartan Medoxomil Tablet
Product Images NDC 70748-237

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Azilsartan Medoxomil (NDC 70748-237). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 1 (F05aba4d 376f 460f 9264 Ecf267e04dcd 01)

Chemical structure of azilsartan medoxomil, the active ingredient in the prescription drug Azilsartan medoxomil tablets by Lupin Pharmaceuticals, Inc.*

FDA Label Image

Image (F05aba4d 376f 460f 9264 Ecf267e04dcd 02)

A pharmacokinetic chart depicting fold change and 90% confidence intervals for various population groups of Azilsartan medoxomil. It compares parameters Cmax and AUC across age, gender, race, renal impairment, hepatic impairment, and pediatric categories, showing recommendations related to dose adjustment.*

FDA Label Image

Image (F05aba4d 376f 460f 9264 Ecf267e04dcd 03)

Line graph showing the effect of Azilsartan Medoxomil Tablets 80 mg compared to placebo, Olmesartan 40 mg, and Valsartan 320 mg on systolic blood pressure over a 24-hour postdose period. The y-axis represents systolic blood pressure in mm Hg, and the x-axis shows hours after dosing. The graph includes four data series with distinct markers.*

FDA Label Image

Image (F05aba4d 376f 460f 9264 Ecf267e04dcd 04)

Line graph depicting diastolic blood pressure (mm Hg) over 24 hours postdose comparing Azilsartan medoxomil 80 mg tablets, placebo, Olmesartan 40 mg, and Valsartan 320 mg. The y-axis shows blood pressure from 65 to 105 mm Hg; the x-axis shows hours postdose from 0 to 24. The graph shows the blood pressure trends of each treatment group over time.*

FDA Label Image

40 mg (F05aba4d 376f 460f 9264 Ecf267e04dcd 05)

Azilsartan Medoxomil Tablets 40 mg oral tablets label displaying a bottle containing 30 tablets. The label indicates the product is manufactured for Lupin Pharmaceuticals, Inc., Naples, FL, and made in India by Lupin Limited. Storage instructions and dosage information are partially visible, along with the NDC 70748-236-06 and Lupin logo on a green and white background.*

FDA Label Image

80 mg (F05aba4d 376f 460f 9264 Ecf267e04dcd 06)

Azilsartan Medoxomil Tablets 80 mg oral tablets label showing NDC 70748-237-06. The label indicates 30 tablets per container, manufactured for Lupin Pharmaceuticals, Inc. The label includes storage instructions, dosage note reference, and manufacturer location in India. The Lupin logo appears on a green vertical strip on the left.*

FDA Label Image

Image (F05aba4d 376f 460f 9264 Ecf267e04dcd 109 1)

Azilsartan medoxomil 40 mg oral tablet packaging label showing a white tablet with a score line, held between a thumb and forefinger above a reflective surface with a stylized design. The label indicates Lupin Pharmaceuticals, Inc. as the manufacturer.*

FDA Label Image

Image (F05aba4d 376f 460f 9264 Ecf267e04dcd 95 1)

Azilsartan medoxomil 40 mg oral tablet packaging label from Lupin Pharmaceuticals, Inc. The label shows a white background with black and green text, including the product name, dosage strength, and tablet form shown in the image. The label includes a barcode and other regulatory information on the side.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.